CFHR2 Gene Hemolytic Uremic Syndrome Genetic Test
Welcome to DNA Labs UAE, a leading genetic lab offering comprehensive genetic testing services. In this blog, we will discuss the CFHR2 Gene Hemolytic Uremic Syndrome Genetic Test, including its components, cost, symptoms, diagnosis, and more.
Test Name: CFHR2 Gene Hemolytic Uremic Syndrome Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hepatology, Nephrology, Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information:
Prior to undergoing the CFHR2 Gene Hemolytic Uremic Syndrome Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by CFHR2 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test gene CFHR2.
Test Details:
The CFHR2 gene plays a crucial role in regulating the complement system, which is responsible for defending against infections. Mutations in the CFHR2 gene have been associated with an increased risk of developing hemolytic uremic syndrome (HUS), a rare condition characterized by the destruction of red blood cells, kidney damage, and low platelet count.
NGS (Next-Generation Sequencing) genetic testing is a powerful method used to analyze multiple genes simultaneously and identify any mutations or variations that may be present. In the case of hemolytic uremic syndrome, NGS genetic testing can detect mutations in the CFHR2 gene, aiding in the diagnosis of the condition.
By identifying these mutations, healthcare professionals can provide a more accurate diagnosis, assess the risk of complications, and determine the most appropriate treatment and management options for individuals with HUS. Furthermore, genetic testing can also identify other family members who may be at risk of developing the condition, enabling early intervention and preventive measures.
At DNA Labs UAE, we are committed to providing high-quality genetic testing services. Our CFHR2 Gene Hemolytic Uremic Syndrome Genetic Test offers valuable insights into the risk and management of this rare condition. To learn more or schedule an appointment, please contact our team.
Test Name | CFHR2 Gene Hemolytic uremic syndrome Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CFHR2 Gene Hemolytic uremic syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CFHR2 Gene Hemolytic uremic syndrome NGS Genetic DNA Test gene CFHR2 |
Test Details |
The CFHR2 gene is involved in the regulation of the complement system, which is a part of the immune system that helps to defend against infections. Mutations in the CFHR2 gene have been associated with an increased risk of developing hemolytic uremic syndrome (HUS), a rare condition characterized by the destruction of red blood cells, kidney damage, and low platelet count. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify any mutations or variations that may be present. In the case of hemolytic uremic syndrome, NGS genetic testing can be used to detect mutations in the CFHR2 gene that may be contributing to the development of the condition. By identifying these mutations, healthcare professionals can provide a more accurate diagnosis, assess the risk of complications, and determine the most appropriate treatment and management options for individuals with HUS. Additionally, genetic testing can also help identify other family members who may be at risk of developing the condition, allowing for early intervention and preventive measures. |